Specialty Pharma Journal Specialty, Precision & Technology
SAN FRANCISCO–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health Corporation (NYSE:CVS). The transaction is valued at $735 million, or approximately $635 million net of the present value of incremental …
Tag Archives: cvs
November, 2017
January, 2015
-
8 January
Gilead Inks Exclusive Deal with CVS Health for Hepatitis C Drugs
Gilead Sciences Inc.’s shares were up more than two percent Monday following news that the company gained exclusive coverage from CVS Health Corp. CVS Health, the nation’s second-largest pharmacy benefit managers (PBM), said that it would make Gilead’s drugs, Harvoni and Sovaldi, the exclusive option for patients on its commercial …